These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38912979)

  • 21. Black girls and referrals: racial and gender disparities in self-reported referral to substance use disorder assessment among justice-involved children.
    Johnson ME; Lloyd SL; Bristol SC; Elliott AL; Cottler LB
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):68. PubMed ID: 36242056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subjective effects as predictors of substance use disorders in a clinical sample: A longitudinal study.
    Gresko SA; Rieselbach M; Corley RP; Hopfer CJ; Stallings MC; Hewitt JK; Rhee SH
    Drug Alcohol Depend; 2023 Aug; 249():110822. PubMed ID: 37331303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonfatal Firearm Injury and Firearm Mortality in High-risk Youths and Young Adults 25 Years After Detention.
    Zheng N; Abram KM; Welty LJ; Aaby DA; Meyerson NS; Teplin LA
    JAMA Netw Open; 2023 Apr; 6(4):e238902. PubMed ID: 37083667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Youth in transition: Study protocol of a prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment.
    Moska C; Goudriaan AE; Blanken P; van de Mheen D; Spijkerman R; Schellekens A; de Jonge J; Bary F; Vollebergh W; Hendriks V
    BMC Psychiatry; 2021 Dec; 21(1):605. PubMed ID: 34863131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.
    Wilens TE; Biederman J; Martelon M; Zulauf C; Anderson JP; Carrellas NW; Yule A; Wozniak J; Fried R; Faraone SV
    J Clin Psychiatry; 2016 Oct; 77(10):1420-1427. PubMed ID: 27574842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders.
    Evans EA; Grella CE; Washington DL; Upchurch DM
    Drug Alcohol Depend; 2017 May; 174():128-136. PubMed ID: 28324815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
    McCabe SE; West BT; Strobbe S; Boyd CJ
    J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing racial and ethnic disparities in premature exits from permanent supportive housing among residents with substance use disorders.
    Panadero TJ; Gabrielian S; Seamans MJ; Gelberg L; Tsai J; Harris T
    Res Sq; 2024 Jun; ():. PubMed ID: 38883791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder.
    Coetzee C; Truter I; Meyer A
    S Afr J Psychiatr; 2022; 28():1786. PubMed ID: 35547103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults.
    Kahle EM; Veliz P; McCabe SE; Boyd CJ
    Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration.
    Williams EC; Fletcher OV; Frost MC; Harris AHS; Washington DL; Hoggatt KJ
    JAMA Netw Open; 2022 Jun; 5(6):e2219651. PubMed ID: 35771574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Firearm homicide and other causes of death in delinquents: a 16-year prospective study.
    Teplin LA; Jakubowski JA; Abram KM; Olson ND; Stokes ML; Welty LJ
    Pediatrics; 2014 Jul; 134(1):63-73. PubMed ID: 24936005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV testing among people with and without substance use disorder in emergency departments: A nationwide cohort study.
    Kimmel SD; Anderson ES; Larochelle MR
    Am J Emerg Med; 2021 Oct; 48():269-272. PubMed ID: 34015610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Analysis of Substance Use Disorder Symptom Severity at Age 18 Years and Substance Use Disorder in Adulthood.
    McCabe SE; Schulenberg JE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2022 Apr; 5(4):e225324. PubMed ID: 35363270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
    Schieber LZ; Dunphy C; Schieber RA; Lopes-Cardozo B; Moonesinghe R; Guy GP
    JAMA Psychiatry; 2023 Apr; 80(4):331-341. PubMed ID: 36790774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and Ethnic Disparities Among Pregnancies with Substance Use Disorder: Impact on Perinatal Outcomes.
    Ragsdale AS; Al-Hammadi N; Bass S; Chavan NR
    J Womens Health (Larchmt); 2024 Sep; 33(9):1166-1174. PubMed ID: 38407821
    [No Abstract]   [Full Text] [Related]  

  • 39. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance Use Treatment Utilization Among Individuals With Substance Use Disorders in the United States During the COVID-19 Pandemic: Findings on the Role of Polysubstance Use, Criminal Justice Involvement, and Mental Illness From the National Survey on Drug Use and Health.
    Apsley HB; Santos-Lozada AR; Gray J; Hard G; Jones AA
    Subst Use; 2024; 18():29768357241259947. PubMed ID: 38881556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.